| abstract |
An object of the present invention is to provide a pharmaceutical composition capable of sufficiently treating a disorder requiring glucocorticoid emergency treatment (for example, acute adrenal onset). A pharmaceutical composition comprising one or more glucocorticoids and one or more bio / mucoadhesion promoters, wherein the composition treats a disorder requiring glucocorticoid emergency treatment by oral mucosal administration. For absorption into the systemic circulatory system, where the disorder is acute adrenal onset, primary, secondary or tertiary adrenal dysfunction, anaphylactic reaction, Addison's disease, asthma status status, Transfusion reaction, brain edema, severe allergic reaction, acute asthma, acute anaphylaxis, septic shock, acute bacterial meningitis, acute RSV (respiratory syncytial virus) infection with bronchiolitis in children, children Acute upper airway stenosis, complication of mononucleosis (including airway obstruction, thrombocytopenia or hemolytic anemia), tonsillitis / peritonsillitis, inflammatory disorder, autoimmune disorder or guru One or more glucocorticoids and one or more bio / mucoadhesion promoters, characterized in that the corticoids are selected from the group consisting of medical disorders that form part of first-line emergency care or short-term intensive care The above-described problems are solved by a pharmaceutical composition containing the same. [Selection figure] None |